Delos Wealth Advisors’s Sanofi SNY Stock Holding History

Delos Wealth Advisors’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-18	Closed	-$896	–	451
2023 Q4	$896	Hold	18	–	–	﹤0.01%	198
2023 Q3	$958	Hold	18	–	–	﹤0.01%	226
2023 Q2	$971	Hold	18	–	–	﹤0.01%	221
2023 Q1	$980	Hold	18	–	–	﹤0.01%	223
2022 Q4	$872	Hold	18	–	–	﹤0.01%	246
2022 Q3	$1K	Buy	+18	New	+$802	﹤0.01%	270

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

Delos Wealth Advisors's SNY Position: Q1 2024 in Review

Delos Wealth Advisors sold out of Sanofi (SNY) in Q1 2024, closing a stake of 18 shares — an estimated $896 sold.

Delos Wealth Advisors first reported a position in SNY in Q3 2022 and held it in 6 quarters. The position peaked at $1K in Q3 2022. 713 funds tracked by Wall St. Rank hold SNY as of Q1 2024.

Delos Wealth Advisors reported no remaining Sanofi position as of Q1 2024 after selling out during the quarter.
Delos Wealth Advisors sold 18 Sanofi shares in Q1 2024, an estimated $896.
Delos Wealth Advisors first reported a position in Sanofi in Q3 2022 and held it in 6 quarters.
Delos Wealth Advisors's Sanofi position peaked at $1K in Q3 2022.
713 funds tracked by Wall St. Rank held Sanofi as of Q1 2024.

Based on Delos Wealth Advisors's 13F filing for Q1 2024, filed 9 May 2024.